LINC02049

Across TCGA pan-cancer cohorts, LINC02049 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated LINC02049 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02049 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02049 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

LIHC, KIRC, and STAD are the cancer types where LINC02049 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	II,III,IV	0.051	0.716	<.001	72	view →
KIRC	OS	Tertile	II,III,IV	0.510	0.817	.002	51	view →
STAD	DFS	Tertile	II,III,IV	0.192	0.701	<.001	48	view →
UCEC	DFS	Tertile	All	0.756	0.901	<.001	48	view →
SARC	DFS	Tertile	All	0.179	0.529	<.001	45	view →
LGG	OS	Tertile	All	0.807	0.409	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LINC02049–LIHC (OS)

Open the LIHC breakdown →